ARTICLE SUMMARY:
Cleveland Clinic spin-out Infuseon has developed a multi-port catheter technology designed to deliver chemotherapy drugs safely and effectively directly into cancerous tissues in the brain—a significant challenge that has remained unsolved. The company has plans to address other high-impact pathologies with its drug delivery technology, including neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease, stroke and epilepsy.
Despite significant advances in cancer diagnosis and therapy, primary brain cancer remains a devastating diagnosis associated with high mortality.
